Ranbaxy Laboratories Ltd. - Research Center
500359 RANBAXY Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Dec' 14 |
Sep' 14 |
Jun' 14 |
Mar' 14 |
Dec' 13 |
Sales |
1,009.85 |
1,318.91 |
2,178.63 |
1,252.02 |
1,366.56 |
Operating profit |
-351.50 |
-155.67 |
926.39 |
-37.66 |
-66.05 |
Interest |
149.31 |
136.82 |
141.91 |
110.85 |
118.39 |
Gross profit |
-483.05 |
-272.47 |
810.24 |
488.00 |
-163.84 |
EPS (Rs) |
-33.46 |
-8.69 |
17.83 |
21.21 |
-9.36 |
Quarterly
results in details
|
Dec' 14 |
Sep' 14 |
Jun' 14 |
Mar' 14 |
Dec' 13 |
Other income |
17.75 |
20.02 |
25.76 |
636.50 |
20.60 |
Stock adjustment |
46.07 |
101.17 |
102.74 |
3.29 |
-82.70 |
Raw material |
314.13 |
335.94 |
280.73 |
394.87 |
432.75 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
271.89 |
279.67 |
254.74 |
226.27 |
271.91 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
729.27 |
757.81 |
614.03 |
665.25 |
810.65 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
54.81 |
60.15 |
65.65 |
49.98 |
45.85 |
Taxation |
855.35 |
- |
9.24 |
30.57 |
- |
Net profit / loss |
-1,420.49 |
-368.26 |
755.12 |
897.86 |
-395.96 |
Extra ordinary item |
-27.27 |
-35.63 |
19.77 |
490.41 |
-186.28 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
212.24 |
211.95 |
211.78 |
211.66 |
211.55 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
1562.90 |
1493.14 |
1448.53 |
1487.74 |
1480.02 |
Agg.of non promotoholding (%) |
36.77 |
35.22 |
34.18 |
35.11 |
34.93 |
OPM (%) |
-34.81 |
-11.80 |
42.52 |
-3.01 |
-4.83 |
GPM (%) |
-47.01 |
-20.35 |
36.76 |
25.84 |
-11.81 |
NPM (%) |
-138.23 |
-27.50 |
34.26 |
47.54 |
-28.54 |